Differential transcriptional activation of matrix metalloproteinase-2 and membrane type-1 matrix metalloproteinase by experimental deep venous thrombosis and thrombin

Journal of Vascular Surgery

Volumn 42, Issue 3, 2005, Pages 539-545

  Dahi, Sia ^a   Lee, Jackie G ^a   Lovett, David H ^b   Sarkar, Rajabrata ^a,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA GALACTOSIDASE; GELATINASE A; MATRIX METALLOPROTEINASE 14; MESSENGER RNA; THROMBIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DIFFERENTIATION; CELL INFILTRATION; CELL LINE; CELL LYSATE; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; DOWN REGULATION; EMBRYO; ENDOTHELIUM CELL; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INDUCTION; FIBROSIS; GENE INDUCTION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; HYPOTHESIS; IMMUNOHISTOCHEMISTRY; INFLAMMATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; REAL TIME POLYMERASE CHAIN REACTION; THROMBUS; UPREGULATION; VASCULAR ENDOTHELIUM; VEIN LIGATION; VEIN WALL; ZYMOGRAPHY;

ANIMALS; BETA-GALACTOSIDASE; CELLS, CULTURED; ENDOTHELIUM, VASCULAR; IMMUNOENZYME TECHNIQUES; MATRIX METALLOPROTEINASE 14; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASES, MEMBRANE-ASSOCIATED; METALLOENDOPEPTIDASES; MICE; MICE, TRANSGENIC; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; THROMBIN; TRANS-ACTIVATION (GENETICS); VENOUS THROMBOSIS;

EID: 24944576056     PISSN: 07415214     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jvs.2005.04.051     Document Type: Article

References (28)

1. P. Prandoni, A.W. Lensing, A. Cogo, S. Cuppini, S. Villalta, M. Carta The long-term clinical course of acute deep venous thrombosis Ann Intern Med 125 1996 1 7
2. C. Kearon Natural history of venous thromboembolism Circulation 107 2003 I22 I30
3. I. Singh, K.G. Burnand, M. Collins, A. Luttun, D. Collen, B. Boelhouwer Failure of thrombus to resolve in urokinase-type plasminogen activator gene-knockout mice rescue by normal bone marrow-derived cells Circulation 107 2003 869 875
4. P.K. Henke, A. Varga, S. De, C.B. Deatrick, J. Eliason, D.A. Arenberg Deep vein thrombosis resolution is modulated by monocyte CXCR2-mediated activity in a mouse model Arterioscler Thromb Vasc Biol 24 2004 1130 1137
5. D.P. Mason, R.D. Kenagy, D. Hasenstab, D.F. Bowen-Pope, R.A. Seifert, S. Coats Matrix metalloproteinase-9 overexpression enhances vascular smooth muscle cell migration and alters remodeling in the injured rat carotid artery Circ Res 85 1999 1179 1185
6. C. Johnson, H.J. Sung, S.M. Lessner, M.E. Fini, Z.S. Galis Matrix metalloproteinase-9 is required for adequate angiogenic revascularization of ischemic tissues potential role in capillary branching Circ Res 94 2004 262 268
7. G.M. Longo, W. Xiong, T.C. Greiner, Y. Zhao, N. Fiotti, T.C. Baxter Matrix metalloproteinases 2 and 9 work in concert to produce aortic aneurysms J Clin Invest 110 2002 625 632
8. B.G. Galvez, S. Matias-Roman, J.P. Albar, F. Sanchez-Madrid, A.G. Arroyo Membrane type 1-matrix metalloproteinase is activated during migration of human endothelial cells and modulates endothelial motility and matrix remodeling J Biol Chem 276 2001 37491 37500
9. A. Janowska-Wieczorek, L.A. Marquez, J.M. Nabholtz, M.L. Cabuhat, J. Montano, H. Chang Growth factors and cytokines upregulate gelatinase expression in bone marrow CD34(+) cells and their transmigration through reconstituted basement membrane Blood 93 1999 3379 3390
10. M. Takahashi, S. Fukami, N. Iwata, K. Inoue, S. Itohara, H. Itoh In vivo glioma growth requires host-derived matrix metalloproteinase 2 for maintenance of angioarchitecture Pharmacol Res 46 2002 155 163
11. K. Ohno-Matsui, T. Uetama, T. Yoshida, M. Hayano, T. Itoh, I. Morita Reduced retinal angiogenesis in MMP-2-deficient mice Invest Ophthalmol Vis Sci 44 2003 5370 5375
12. Z. Zhou, S.S. Apte, R. Soininen, R. Cao, G.Y. Baaklini, R.W. Rauser Impaired endochondral ossification and angiogenesis in mice deficient in membrane-type matrix metalloproteinase I Proc Natl Acad Sci U S A 97 2000 4052 4057
13. S. Zucker, C. Conner, B.I. DiMassmo, H. Ende, M. Drews, M. Seiki Thrombin induces the activation of progelatinase A in vascular endothelial cells. Physiologic regulation of angiogenesis J Biol Chem 270 1995 23730 23738
14. M.A. Lafleur, M.D. Hollenberg, S.J. Atkinson, V. Knauper, G. Murphy, D.R. Edwards Activation of pro-(matrix metalloproteinase-2) (pro-MMP-2) by thrombin is membrane-type-MMP-dependent in human umbilical vein endothelial cells and generates a distinct 63 kDa active species Biochem J 357 2001 107 115
15. M. Nguyen, J. Arkell, C.J. Jackson Activated protein C directly activates human endothelial gelatinase A J Biol Chem 275 2000 9095 9098
16. B.H. Rauch, E. Bretschneider, M. Braun, K. Schror Factor Xa releases matrix metalloproteinase-2 (MMP-2) from human vascular smooth muscle cells and stimulates the conversion of pro-MMP-2 to MMP-2 role of MMP-2 in factor Xa-induced DNA synthesis and matrix invasion Circ Res 90 2002 1122 1127
17. M. Nguyen, J. Arkell, C.J. Jackson Human endothelial gelatinases and angiogenesis Int J Biochem Cell Biol 33 2001 960 970
18. B.W. Wang, H. Chang, S. Lin, P. Kuan, K.G. Shyu Induction of matrix metalloproteinases-14 and -2 by cyclical mechanical stretch is mediated by tumor necrosis factor-alpha in cultured human umbilical vein endothelial cells Cardiovasc Res 59 2003 460 469
19. M.R. Bergman, S. Cheng, N. Honbo, L. Piacentini, J.S. Karliner, D.H. Lovett A functional activating protein 1 (AP-1) site regulates matrix metalloproteinase 2 (MMP-2) transcription by cardiac cells through interactions with JunB-Fra1 and JunB-FosB heterodimers Biochem J 369 2003 485 496
20. P.R. Mertens, K. Steinmann, M.A. Alfonso-Jaume, A. En-Nia, Y. Sun, D.H. Lovett Combinatorial interactions of p53, activating protein-2, and YB-1 with a single enhancer element regulate gelatinase A expression in neoplastic cells J Biol Chem 277 2002 24875 24882
21. T.W. Wakefield, M.J. Linn, P.K. Henke, A.M. Kadell, C.A. Wilke, S.K. Wrobleski Neovascularization during venous thrombosis organization a preliminary study J Vasc Surg 30 1999 885 892
22. H. Tschesche, A. Lichte, O. Hiller, A. Oberpichler, F.H. Buttner, E. Bartnik Matrix metalloproteinases (MMP-8, -13, and -14) interact with the clotting system and degrade fibrinogen and factor XII (Hagemann factor) Adv Exp Med Biol 477 2000 217 228
23. B. Muhs, G. Plitas, Y. Delgado, I. Ianus, J.P. Shaw, M.A. Adelman Temporal expression and activation of matrix metalloproteinases-2, -9 and membrane type 1-matrix metalloproteinase following acute hindlimb ischemia J Surg Res 111 2003 8 15
24. M. Kuzuya, S. Kanda, T. Sasaki, N. Tamaya-Mori, X.W. Cheng, T. Itoh Deficiency of gelatinase A suppresses smooth muscle cell invasion and development of experimental intimal hyperplasia Circulation 108 2003 1375 1381
25. D.R. Todor, I. Lewis, G. Bruno, D. Chyatte Identification of a serum gelatinase associated with the occurrence of cerebral aneurysms as pro-matrix metalloproteinase-2 Stroke 29 1998 1580 1583
26. K.H. Boeker, C.I. Haberkorn, D. Michels, P. Flemming, M.P. Manns, R. Lichtinghagen Diagnostic potential of circulating TIMP-1 and MMP-2 as markers of liver fibrosis in patients with chronic hepatitis C Clin Chim Acta 316 2002 71 81
27. G. La Rocca, I. Pucci-Minafra, A. Marrazzo, P. Taormina, S. Minafra Zymographic detection and clinical correlations of MMP-2 and MMP-9 in breast cancer sera Br J Cancer 90 2004 1414 1421
28. Y. Noji, M. Shimizu, H. Ino, T. Higashikata, M. Yamaguchi, A. Nohara Increased circulating matrix metalloproteinase-2 in patients with hypertrophic cardiomyopathy with systolic dysfunction Circ J 68 2004 355 360